Intravenous immunoglobulin | Department of Medicine Blog

Adjunctive Corticosteroid Therapy in Kawasaki Disease: A Meta-Analysis and Trial Sequential Analysis of Randomized Controlled Trials

Khan A, Shah SW, Huma S, Adnan R, Yahya M, Khan A, Adnan W, Habib U, Khan I, Ikram M, Awais M, Ullah U, Mankani[...]

By afschroeder • August 29, 2026

Predictors of response to intravenous immunoglobulin in patients with dermatomyositis: the ProDERM study

Charles-Schoeman C, Schessl J, Bata-Csörgő Z, Dimachkie MM, Griger Z, Moiseev S, Oddis CV, Schiopu E, Vencovský J, Clodi E, Levine T, Aggarwal R. Predictors[...]

By sjmartinez • February 8, 2025

Safety and tolerability of intravenous immunoglobulin in patients with active dermatomyositis: results from the randomised, placebo-controlled ProDERM study

Aggarwal R, Schessl J, Charles-Schoeman C, Bata-Csörgő Z, Dimachkie MM, Griger Z, Moiseev S, Oddis CV, Schiopu E, Vencovský J, Beckmann I, Clodi E, Levine[...]

By sjmartinez • January 18, 2024

Assessment of antibody levels to SARS-CoV-2 in patients with idiopathic inflammatory myopathies receiving treatment with intravenous immunoglobulin

Bae SS, Faure-Kumar E, Ferbas K, Wang J, Shahbazian A, Truong L, Yang H, McMahon M, FitzGerald JD, Charles-Schoeman C. Assessment of antibody levels to[...]

By sjmartinez • June 28, 2023